Sickle Cell Disease Approvals Include First CRISPR Gene Editing Therapy
JAMA
.
2024 Jan 23;331(4):280.
doi: 10.1001/jama.2023.26113.
Author
Emily Harris
PMID:
38170544
DOI:
10.1001/jama.2023.26113
No abstract available
MeSH terms
Anemia, Sickle Cell* / genetics
Anemia, Sickle Cell* / therapy
CRISPR-Cas Systems*
Clustered Regularly Interspaced Short Palindromic Repeats
Gene Editing* / methods
Genetic Therapy* / methods
Humans